iStock
IRVINE, Calif. (AP) _ Edwards Lifesciences Corp. (EW) on Thursday reported third-quarter profit of $343.5 million.
The Irvine, California-based company said it had profit of 55 cents per share. Earnings, adjusted for non-recurring costs, were 61 cents per share.
The results did not meet Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of 62 cents per share.
The medical device maker posted revenue of $1.32 billion in the period, which also fell short of Street forecasts. Eleven analysts surveyed by Zacks expected $1.34 billion.
Edwards Lifesciences expects full-year revenue in the range of $5.35 billion to $5.55 billion.
